- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
ITPKC Antibody recognizes inositol 1,4,5-trisphosphate 3-kinase C (ITPKC), an enzyme involved in phosphoinositide metabolism and intracellular calcium signaling. Also known as IP3KC, this protein belongs to the inositol trisphosphate 3-kinase family, which catalyzes the phosphorylation of inositol 1,4,5-trisphosphate (IP3) to inositol 1,3,4,5-tetrakisphosphate (IP4). By regulating intracellular IP3 concentrations, ITPKC influences calcium release from the endoplasmic reticulum and downstream calcium-dependent signaling pathways.
The human ITPKC gene is located on chromosome 19 and encodes a protein of approximately 683 amino acids. ITPKC contains a conserved catalytic domain responsible for transferring a phosphate group from ATP to IP3. Unlike some related inositol phosphate kinases, ITPKC can localize to both the cytoplasm and nucleus, with nuclear import and export sequences contributing to its intracellular distribution. This localization may allow the enzyme to regulate distinct pools of inositol phosphates and influence signaling processes in different cellular compartments.
ITPKC plays an important regulatory role in immune cell activation. Following stimulation of cell surface receptors, phospholipase C generates IP3, which promotes calcium release from intracellular stores. Elevated cytoplasmic calcium activates calcineurin and nuclear factor of activated T cells (NFAT), supporting transcriptional programs involved in lymphocyte activation and proliferation. By converting IP3 to IP4, ITPKC helps limit the duration and intensity of calcium signaling. The Inositol Trisphosphate 3-Kinase C Polyclonal Antibody is therefore relevant to investigations of calcium-dependent immune regulation and phosphoinositide signaling.
Genetic variation in ITPKC has been associated with susceptibility to Kawasaki disease, an inflammatory condition affecting blood vessels, particularly the coronary arteries. Certain regulatory variants may reduce ITPKC expression, potentially increasing calcium-dependent NFAT signaling and inflammatory responses. Although the relationship between ITPKC polymorphisms and disease susceptibility varies among populations, these findings have established ITPKC as a protein of interest in cardiovascular inflammation and immune-mediated vascular disorders.
Beyond immune regulation, ITPKC contributes to the broader network of inositol phosphate metabolism, which coordinates calcium homeostasis, cellular communication, and responses to extracellular stimulation. Understanding the expression and regulation of this enzyme may provide insight into the mechanisms connecting phosphoinositide turnover with inflammatory signaling. NSJ Bioreagents offers this antibody for research into these biological processes. An ITPKC Antibody provides a tool for examining the expression of inositol trisphosphate 3-kinase C and investigating its role in calcium signaling and immune regulation.
For additional antibodies targeting proteins involved in intracellular signaling pathways, explore our Signal Transduction Antibodies collection.
Optimal dilution of the ITPKC Antibody / Inositol Trisphosphate 3-Kinase C Polyclonal Antibody should be determined by the researcher.
E.coli-derived human ITPKC recombinant protein (Position: D292-E607) was used as the immunogen for the ITPKC antibody.
After reconstitution, the ITPKC antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.